If my testosterone preparation is 200 mg per milliliter, how many milliliters should I draw to administer a 150 mg dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Testosterone Dose Calculation

To administer 150 mg from a 200 mg/mL testosterone preparation, you need to draw 0.75 mL.

Calculation Method

The calculation is straightforward using the concentration formula:

  • Volume needed = Desired dose ÷ Concentration
  • Volume = 150 mg ÷ 200 mg/mL = 0.75 mL 1

Practical Administration Details

Supplies needed for injection:

  • Use an 18-gauge needle to draw the testosterone from the vial 2
  • Use a 21-23 gauge, 1-1.5 inch needle for the actual intramuscular injection 2
  • A 1-3 mL syringe (3 mL is most common for typical testosterone doses) 2
  • Alcohol prep pads for cleaning the vial top and injection site 2

Injection sites:

  • Self-injection can be performed in the anterolateral thigh 3, 2
  • Gluteal intramuscular injection when administered by another person 3, 2
  • The gluteal muscle can safely accommodate up to 3 mL per injection site 2

Clinical Context for 150 mg Dosing

This 150 mg dose falls within standard testosterone replacement therapy ranges:

  • Testosterone enanthate and cypionate are typically dosed at 100-200 mg every 2 weeks or 50-100 mg weekly 3, 2
  • A 150 mg dose could represent either a weekly injection or part of a biweekly regimen 3
  • Weekly dosing (such as 150 mg weekly) provides more stable testosterone levels compared to biweekly administration 2

Important monitoring considerations:

  • Testosterone levels should be measured 2-3 months after treatment initiation or any dose change, checking midway between injections and targeting mid-normal values of 450-600 ng/dL 2, 4
  • Injectable testosterone carries a higher risk of erythrocytosis (43.8%) compared to transdermal preparations (15.4%), so hematocrit monitoring is mandatory 2
  • The 200 mg biweekly regimen is associated with higher erythrocytosis risk than 100 mg weekly due to greater fluctuation in testosterone levels 5

References

Guideline

Testosterone Replacement Therapy Dosing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Testosterone Enanthate Conversion Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What volume (in milliliters (ml)) of a 200mg per 1ml testosterone vial is needed to administer 75mg of testosterone?
Is 0.4ml the correct volume to draw from a 250mg/10ml testosterone solution for a 100mg dose using a 2ml syringe?
What are the guidelines for a male patient with hypogonadism (low testosterone levels) taking 200 mg of testosterone (Testosterone) weekly?
What weekly dose of intramuscular testosterone should a 28‑year‑old male with hypogonadism receive if he is currently on 100 mg weekly and his serum total testosterone is 300 ng/dL?
What is the recommended dose and frequency for testosterone (intramuscular injection) in a female patient when using a 200 mg/ml solution?
What is the recommended starting dose, titration schedule, contraindications, monitoring, and side‑effect management for Invega (paliperidone) in an adult with schizophrenia or schizoaffective disorder?
Is stem cell therapy a recommended treatment for Peyronie's disease in an adult male?
What does it mean to program a pacemaker to VVI 65 bpm after disconnecting the atrial lead in a patient who already has an intrinsic escape rhythm at 65 bpm and a severely dilated ventricle?
How should molluscum contagiosum be managed in an immunocompetent child or adolescent with a limited number of lesions?
What are the current cervical cancer screening guidelines (Pap test and HPV co‑testing), including recommended age intervals, criteria for stopping screening after hysterectomy or age >65, and special considerations for immunocompromised patients, pregnancy, and HPV‑vaccinated women?
How should I manage a premenopausal woman with deep infiltrating endometriosis causing chronic pelvic pain, especially regarding estrogen exposure and hormonal therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.